{"title":"GLP-1","description":"","products":[{"product_id":"tirzepatide-20mg","title":"Tirzepatide 20mg","description":"\u003ch2\u003eTirzepatide — Research Peptide\u003c\/h2\u003e\n\u003cp\u003eTirzepatide is a 39-amino-acid synthetic peptide referenced in the scientific literature as a dual \u003cstrong\u003eGLP-1\u003c\/strong\u003e and \u003cstrong\u003eGIP\u003c\/strong\u003e receptor agonist. It is one of the most extensively profiled compounds within the incretin-class multi-receptor agonist research peptide family.\u003c\/p\u003e\n\n\u003cp\u003e\n  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% (HPLC-MS verified)\u003cbr\u003e\n  \u003cstrong\u003eFormat:\u003c\/strong\u003e 20mg lyophilized vial, sealed amber glass\u003cbr\u003e\n  \u003cstrong\u003eDesignation:\u003c\/strong\u003e Research use only — not intended for human or veterinary use\n\u003c\/p\u003e\n\n\u003ch2\u003eCompound Overview\u003c\/h2\u003e\n\u003cp\u003eTirzepatide is engineered as a unimolecular dual agonist that concurrently engages two structurally related receptor systems within the incretin axis: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). It features a C20 fatty diacid moiety attached via a linker that extends half-life relative to native incretins.\u003c\/p\u003e\n\n\u003cp\u003eWithin peer-reviewed publications, Tirzepatide is frequently positioned between Semaglutide (a single-receptor GLP-1 agonist) and Retatrutide (a unimolecular triple agonist engaging GLP-1, GIP, and glucagon receptors). It is among the most cited investigational peptides in current metabolic and endocrine research literature.\u003c\/p\u003e\n\n\u003ch2\u003eResearch Context\u003c\/h2\u003e\n\u003cp\u003eTirzepatide has been investigated in published research literature and is commonly referenced in laboratory work involving:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eComparative incretin receptor pharmacology\u003c\/li\u003e\n  \u003cli\u003eDual-receptor unimolecular peptide structure–activity research\u003c\/li\u003e\n  \u003cli\u003eGlucose homeostasis and metabolic signaling research\u003c\/li\u003e\n  \u003cli\u003eComparative pharmacokinetics across GLP-1 \/ GIP \/ glucagon agonists\u003c\/li\u003e\n  \u003cli\u003eEnergy substrate signaling pathway models\u003c\/li\u003e\n  \u003cli\u003eLong-acting peptide design and fatty acid acylation strategies\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eScientific Classification\u003c\/h2\u003e\n\u003ctable\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCompound name\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eTirzepatide\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eMolecular class\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSynthetic peptide (39 amino acids)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFunctional category\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eDual GLP-1 \/ GIP receptor agonist\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePeptide family\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eIncretin-class multi-receptor agonist research peptides\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eResearch domains\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eIncretin biology, GLP-1 and GIP receptor pharmacology, metabolic signaling, comparative incretin peptide research\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAdjacent compounds\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSemaglutide, Retatrutide, Cagrilintide, Survodutide, Mazdutide, AOD9604, HGH Fragment 176-191\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eAnalytical \u0026amp; Quality Standards\u003c\/h2\u003e\n\u003cp\u003eEvery Tirzepatide lot supplied by DISSOLV LABS undergoes a structured analytical workflow designed to confirm identity, purity, and batch consistency before release.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePurity verification\u003c\/strong\u003e by reversed-phase high-performance liquid chromatography (RP-HPLC)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIdentity confirmation\u003c\/strong\u003e by mass spectrometry (HPLC-MS)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResidual solvent and moisture screening\u003c\/strong\u003e to documented thresholds\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBatch-to-batch consistency\u003c\/strong\u003e recorded on a per-lot Certificate of Analysis (COA)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThird-party verification\u003c\/strong\u003e available upon institutional request\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSterile lyophilization\u003c\/strong\u003e under inert conditions to preserve peptide integrity\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eTechnical Specifications\u003c\/h2\u003e\n\u003ctable\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFormat\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e20mg lyophilized vial\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAppearance\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eUniform, free-flowing white lyophilized solid\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePackaging\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSealed amber glass vial, crimped seal\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCatalog identifier\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eDSL-TIRZ-0020\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePurity\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e≥99% (HPLC-MS verified)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eRecommended storage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e−20 °C, protected from light and moisture\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eReconstitution\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSterile or bacteriostatic solvent (laboratory protocol only)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eStability\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eStable under recommended storage conditions; refer to lot COA\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eHandling\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eRestricted to qualified research personnel\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow does Tirzepatide differ from Semaglutide and Retatrutide?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eIn published research literature, Semaglutide is described as a selective GLP-1 receptor agonist, Tirzepatide as a dual GLP-1\/GIP agonist, and Retatrutide as a unimolecular triple agonist engaging GLP-1, GIP, and glucagon receptors. Each compound occupies a distinct position within the incretin-class research peptide hierarchy.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow does Tirzepatide differ from Survodutide and Mazdutide?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eTirzepatide is a dual GLP-1\/GIP agonist; Survodutide and Mazdutide are dual GLP-1\/glucagon agonists. All three are studied within the broader unimolecular multi-agonist incretin research literature but engage distinct receptor pair combinations.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat purity standard does DISSOLV LABS supply?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eDISSOLV LABS supplies Tirzepatide at \u003cstrong\u003e≥99% purity\u003c\/strong\u003e, verified by reversed-phase HPLC and confirmed by mass spectrometry (HPLC-MS). Each lot is accompanied by a Certificate of Analysis.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat analytical testing is performed on each lot?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eEach Tirzepatide lot is subjected to RP-HPLC purity analysis, HPLC-MS identity confirmation, residual solvent and moisture screening, and batch-consistency documentation. Third-party analytical verification is available upon institutional request.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow should Tirzepatide be stored?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eRecommended storage is \u003cstrong\u003e−20 °C\u003c\/strong\u003e, protected from light and moisture, in the original sealed vial. Refer to the lot-specific Certificate of Analysis for stability data.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow is Tirzepatide reconstituted for laboratory work?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eTirzepatide is typically reconstituted with sterile or bacteriostatic solvent in accordance with the receiving laboratory's internal protocols. Reconstitution methodology is the responsibility of the qualified research professional.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eIs Tirzepatide research use only?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eYes. Tirzepatide supplied by DISSOLV LABS is \u003cstrong\u003estrictly for laboratory research use only\u003c\/strong\u003e. It is not intended for human or veterinary use, and is not intended to diagnose, treat, cure, or prevent any disease.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eIs a Certificate of Analysis (COA) available?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eYes. Every lot is shipped with a lot-specific Certificate of Analysis documenting purity, identity, and analytical methodology. COAs are available to verified research accounts on request.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWho should handle Tirzepatide?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eTirzepatide is intended exclusively for handling by qualified laboratory research professionals operating within appropriate research facilities. It is not for sale to or use by the general public.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003ch2\u003eRelated Research Compounds\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003cstrong\u003eSemaglutide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eRetatrutide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eCagrilintide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eSurvodutide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eMazdutide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eAOD9604\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eHGH Fragment 176-191\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eCompliance\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only.\u003c\/strong\u003e This product is not intended for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Sale and distribution are restricted to qualified laboratory research professionals operating within appropriate research environments. The purchaser assumes full responsibility for safe handling, storage, and disposal in accordance with applicable institutional, local, and federal guidelines.\u003c\/p\u003e","brand":"DISSOLV LABS","offers":[{"title":"Default Title","offer_id":52102992101656,"sku":"DSL-TIRZ-0020","price":34.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0987\/0861\/9544\/files\/Trizepatide20mg.png?v=1779526158"},{"product_id":"tirzepatide-30mg","title":"Tirzepatide 30mg","description":"\u003ch2\u003eTirzepatide — Research Peptide\u003c\/h2\u003e\n\u003cp\u003eTirzepatide is a 39-amino-acid synthetic peptide referenced in the scientific literature as a dual \u003cstrong\u003eGLP-1\u003c\/strong\u003e and \u003cstrong\u003eGIP\u003c\/strong\u003e receptor agonist, supplied here in a 30 mg lyophilized vial format for extended-volume laboratory research.\u003c\/p\u003e\n\n\u003cp\u003e\n  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% (HPLC-MS verified)\u003cbr\u003e\n  \u003cstrong\u003eFormat:\u003c\/strong\u003e 30mg lyophilized vial, sealed amber glass\u003cbr\u003e\n  \u003cstrong\u003eDesignation:\u003c\/strong\u003e Research use only — not intended for human or veterinary use\n\u003c\/p\u003e\n\n\u003ch2\u003eCompound Overview\u003c\/h2\u003e\n\u003cp\u003eTirzepatide is engineered as a unimolecular dual agonist that concurrently engages two structurally related receptor systems within the incretin axis: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). It features a C20 fatty diacid moiety attached via a linker that extends half-life relative to native incretins.\u003c\/p\u003e\n\n\u003cp\u003eThe 30 mg vial format offers a higher peptide content per vial than the 20 mg specification, suited to laboratory workflows requiring expanded comparative or repeat-assay material. Tirzepatide is frequently positioned between Semaglutide (a single-receptor GLP-1 agonist) and Retatrutide (a unimolecular triple agonist).\u003c\/p\u003e\n\n\u003ch2\u003eResearch Context\u003c\/h2\u003e\n\u003cp\u003eTirzepatide has been investigated in published research literature and is commonly referenced in laboratory work involving:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eComparative incretin receptor pharmacology\u003c\/li\u003e\n  \u003cli\u003eDual-receptor unimolecular peptide structure–activity research\u003c\/li\u003e\n  \u003cli\u003eGlucose homeostasis and metabolic signaling research\u003c\/li\u003e\n  \u003cli\u003eComparative pharmacokinetics across GLP-1 \/ GIP \/ glucagon agonists\u003c\/li\u003e\n  \u003cli\u003eEnergy substrate signaling pathway models\u003c\/li\u003e\n  \u003cli\u003eLong-acting peptide design and fatty acid acylation strategies\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eScientific Classification\u003c\/h2\u003e\n\u003ctable\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCompound name\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eTirzepatide\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eMolecular class\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSynthetic peptide (39 amino acids)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFunctional category\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eDual GLP-1 \/ GIP receptor agonist\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePeptide family\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eIncretin-class multi-receptor agonist research peptides\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eResearch domains\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eIncretin biology, GLP-1 and GIP receptor pharmacology, metabolic signaling, comparative incretin peptide research\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAdjacent compounds\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSemaglutide, Retatrutide, Cagrilintide, Survodutide, Mazdutide, AOD9604, HGH Fragment 176-191\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eAnalytical \u0026amp; Quality Standards\u003c\/h2\u003e\n\u003cp\u003eEvery Tirzepatide lot supplied by DISSOLV LABS undergoes a structured analytical workflow designed to confirm identity, purity, and batch consistency before release.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePurity verification\u003c\/strong\u003e by reversed-phase high-performance liquid chromatography (RP-HPLC)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIdentity confirmation\u003c\/strong\u003e by mass spectrometry (HPLC-MS)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResidual solvent and moisture screening\u003c\/strong\u003e to documented thresholds\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBatch-to-batch consistency\u003c\/strong\u003e recorded on a per-lot Certificate of Analysis (COA)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThird-party verification\u003c\/strong\u003e available upon institutional request\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSterile lyophilization\u003c\/strong\u003e under inert conditions to preserve peptide integrity\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eTechnical Specifications\u003c\/h2\u003e\n\u003ctable\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFormat\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e30mg lyophilized vial\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAppearance\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eUniform, free-flowing white lyophilized solid\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePackaging\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSealed amber glass vial, crimped seal\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCatalog identifier\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eDSL-TIRZ-0030\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePurity\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e≥99% (HPLC-MS verified)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eRecommended storage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e−20 °C, protected from light and moisture\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eReconstitution\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSterile or bacteriostatic solvent (laboratory protocol only)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eStability\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eStable under recommended storage conditions; refer to lot COA\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eHandling\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eRestricted to qualified research personnel\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow does the 30 mg vial differ from the 20 mg vial?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eThe 20 mg and 30 mg formats are analytically identical — same compound, same ≥99% purity specification, same lyophilization protocol. They differ only in total peptide content per vial.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow does Tirzepatide differ from Semaglutide and Retatrutide?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eSemaglutide is described as a selective GLP-1 agonist, Tirzepatide as a dual GLP-1\/GIP agonist, and Retatrutide as a unimolecular triple agonist engaging GLP-1, GIP, and glucagon receptors.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat purity standard does DISSOLV LABS supply?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eDISSOLV LABS supplies Tirzepatide at \u003cstrong\u003e≥99% purity\u003c\/strong\u003e, verified by reversed-phase HPLC and confirmed by mass spectrometry (HPLC-MS). Each lot is accompanied by a Certificate of Analysis.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat analytical testing is performed on each lot?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eEach Tirzepatide lot is subjected to RP-HPLC purity analysis, HPLC-MS identity confirmation, residual solvent and moisture screening, and batch-consistency documentation. Third-party analytical verification is available upon institutional request.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow should Tirzepatide be stored?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eRecommended storage is \u003cstrong\u003e−20 °C\u003c\/strong\u003e, protected from light and moisture, in the original sealed vial. Refer to the lot-specific Certificate of Analysis for stability data.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow is Tirzepatide reconstituted for laboratory work?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eTirzepatide is typically reconstituted with sterile or bacteriostatic solvent in accordance with the receiving laboratory's internal protocols. Reconstitution methodology is the responsibility of the qualified research professional.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eIs Tirzepatide research use only?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eYes. Tirzepatide supplied by DISSOLV LABS is \u003cstrong\u003estrictly for laboratory research use only\u003c\/strong\u003e. It is not intended for human or veterinary use, and is not intended to diagnose, treat, cure, or prevent any disease.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eIs a Certificate of Analysis (COA) available?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eYes. Every lot is shipped with a lot-specific Certificate of Analysis documenting purity, identity, and analytical methodology. COAs are available to verified research accounts on request.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWho should handle Tirzepatide?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eTirzepatide is intended exclusively for handling by qualified laboratory research professionals operating within appropriate research facilities. It is not for sale to or use by the general public.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003ch2\u003eRelated Research Compounds\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003cstrong\u003eSemaglutide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eRetatrutide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eCagrilintide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eSurvodutide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eMazdutide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eAOD9604\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eHGH Fragment 176-191\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eCompliance\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only.\u003c\/strong\u003e This product is not intended for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Sale and distribution are restricted to qualified laboratory research professionals operating within appropriate research environments. The purchaser assumes full responsibility for safe handling, storage, and disposal in accordance with applicable institutional, local, and federal guidelines.\u003c\/p\u003e","brand":"DISSOLV LABS","offers":[{"title":"Default Title","offer_id":52102992134424,"sku":"DSL-TIRZ-0030","price":45.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0987\/0861\/9544\/files\/Trizepatide_30mg.png?v=1779524329"},{"product_id":"retatrutide-10mg","title":"Retatrutide 10mg","description":"\u003ch2\u003eRetatrutide — Research Peptide\u003c\/h2\u003e\n\u003cp\u003eRetatrutide is a synthetic investigational peptide referenced in the scientific literature as a single-molecule triple agonist at the \u003cstrong\u003eGLP-1\u003c\/strong\u003e, \u003cstrong\u003eGIP\u003c\/strong\u003e, and \u003cstrong\u003eglucagon\u003c\/strong\u003e receptor systems.\u003c\/p\u003e\n\n\u003cp\u003e\n  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% (HPLC-MS verified)\u003cbr\u003e\n  \u003cstrong\u003eFormat:\u003c\/strong\u003e 10mg lyophilized vial, sealed amber glass\u003cbr\u003e\n  \u003cstrong\u003eDesignation:\u003c\/strong\u003e Research use only — not intended for human or veterinary use\n\u003c\/p\u003e\n\n\u003ch2\u003eCompound Overview\u003c\/h2\u003e\n\u003cp\u003eRetatrutide is classified within the multi-receptor incretin research peptide family. It is engineered as a unimolecular agonist that concurrently engages three structurally related receptor systems: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon.\u003c\/p\u003e\n\n\u003cp\u003eWithin peer-reviewed publications, Retatrutide is frequently positioned alongside Tirzepatide (a dual GLP-1\/GIP agonist) and Semaglutide (a GLP-1 agonist), and is studied as an extension of the broader incretin-class research lineage. It is among the most extensively profiled investigational peptides in current metabolic and endocrine research literature.\u003c\/p\u003e\n\n\u003ch2\u003eResearch Context\u003c\/h2\u003e\n\u003cp\u003eRetatrutide has been investigated in published research literature and is commonly referenced in laboratory work involving:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eComparative incretin receptor pharmacology\u003c\/li\u003e\n  \u003cli\u003eUnimolecular multi-agonist peptide structure–activity research\u003c\/li\u003e\n  \u003cli\u003eEnergy substrate signaling pathway models\u003c\/li\u003e\n  \u003cli\u003eGlucose homeostasis and metabolic signaling research\u003c\/li\u003e\n  \u003cli\u003eComparative peptide pharmacokinetics and stability profiling\u003c\/li\u003e\n  \u003cli\u003eReceptor binding affinity and selectivity studies\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eScientific Classification\u003c\/h2\u003e\n\u003ctable\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCompound name\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eRetatrutide\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eMolecular class\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSynthetic peptide\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFunctional category\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eUnimolecular triple agonist (GLP-1 \/ GIP \/ glucagon)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePeptide family\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eIncretin-class multi-receptor agonist research peptides\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eResearch domains\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eIncretin biology, metabolic signaling, peptide pharmacology, receptor agonism\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAdjacent compounds\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eTirzepatide, Semaglutide, Cagrilintide, Cagrisema, Survodutide, Mazdutide, AOD9604, HGH Fragment 176-191\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eAnalytical \u0026amp; Quality Standards\u003c\/h2\u003e\n\u003cp\u003eEvery Retatrutide lot supplied by DISSOLV LABS undergoes a structured analytical workflow designed to confirm identity, purity, and batch consistency before release.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePurity verification\u003c\/strong\u003e by reversed-phase high-performance liquid chromatography (RP-HPLC)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIdentity confirmation\u003c\/strong\u003e by mass spectrometry (HPLC-MS)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResidual solvent and moisture screening\u003c\/strong\u003e to documented thresholds\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBatch-to-batch consistency\u003c\/strong\u003e recorded on a per-lot Certificate of Analysis (COA)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThird-party verification\u003c\/strong\u003e available upon institutional request\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSterile lyophilization\u003c\/strong\u003e under inert conditions to preserve peptide integrity\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eTechnical Specifications\u003c\/h2\u003e\n\u003ctable\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFormat\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e10mg lyophilized vial\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAppearance\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eUniform, free-flowing white lyophilized solid\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePackaging\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSealed amber glass vial, crimped seal\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCatalog identifier\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eDSL-RETA-0010\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePurity\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e≥99% (HPLC-MS verified)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eRecommended storage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e−20 °C, protected from light and moisture\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eReconstitution\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSterile or bacteriostatic solvent (laboratory protocol only)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eStability\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eStable under recommended storage conditions; refer to lot COA\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eHandling\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eRestricted to qualified research personnel\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow does Retatrutide differ from Tirzepatide and Semaglutide?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eSemaglutide is described as a single-receptor GLP-1 agonist, Tirzepatide as a dual GLP-1\/GIP agonist, and Retatrutide as a unimolecular triple agonist engaging GLP-1, GIP, and glucagon receptors. Each compound occupies a distinct position within the incretin-class research peptide hierarchy.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat purity standard does DISSOLV LABS supply?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eDISSOLV LABS supplies Retatrutide at \u003cstrong\u003e≥99% purity\u003c\/strong\u003e, verified by reversed-phase HPLC and confirmed by mass spectrometry (HPLC-MS). Each lot is accompanied by a Certificate of Analysis.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat analytical testing is performed on each lot?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eEach Retatrutide lot is subjected to RP-HPLC purity analysis, HPLC-MS identity confirmation, residual solvent and moisture screening, and batch-consistency documentation. Third-party analytical verification is available upon institutional request.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow should Retatrutide be stored?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eRecommended storage is \u003cstrong\u003e−20 °C\u003c\/strong\u003e, protected from light and moisture, in the original sealed vial. Refer to the lot-specific Certificate of Analysis for stability data.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow is Retatrutide reconstituted for laboratory work?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eRetatrutide is typically reconstituted with sterile or bacteriostatic solvent in accordance with the receiving laboratory's internal protocols. Reconstitution methodology is the responsibility of the qualified research professional.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eIs Retatrutide research use only?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eYes. Retatrutide supplied by DISSOLV LABS is \u003cstrong\u003estrictly for laboratory research use only\u003c\/strong\u003e. It is not intended for human or veterinary use, and is not intended to diagnose, treat, cure, or prevent any disease.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eIs a Certificate of Analysis (COA) available?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eYes. Every lot is shipped with a lot-specific Certificate of Analysis documenting purity, identity, and analytical methodology. COAs are available to verified research accounts on request.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWho should handle Retatrutide?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eRetatrutide is intended exclusively for handling by qualified laboratory research professionals operating within appropriate research facilities. It is not for sale to or use by the general public.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003ch2\u003eRelated Research Compounds\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003cstrong\u003eTirzepatide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eSemaglutide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eCagrilintide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eCagrisema\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eSurvodutide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eMazdutide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eAOD9604\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eHGH Fragment 176-191\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eCompliance\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only.\u003c\/strong\u003e This product is not intended for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Sale and distribution are restricted to qualified laboratory research professionals operating within appropriate research environments. The purchaser assumes full responsibility for safe handling, storage, and disposal in accordance with applicable institutional, local, and federal guidelines.\u003c\/p\u003e","brand":"DISSOLV LABS","offers":[{"title":"Default Title","offer_id":52102992167192,"sku":"DSL-RETA-0010","price":37.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0987\/0861\/9544\/files\/RETATRUTIDE_10mg.png?v=1779678013"},{"product_id":"retatrutide-20mg","title":"Retatrutide 20mg","description":"\u003ch2\u003eRetatrutide — Research Peptide\u003c\/h2\u003e\n\u003cp\u003eRetatrutide is a synthetic investigational peptide referenced in the scientific literature as a single-molecule triple agonist at the \u003cstrong\u003eGLP-1\u003c\/strong\u003e, \u003cstrong\u003eGIP\u003c\/strong\u003e, and \u003cstrong\u003eglucagon\u003c\/strong\u003e receptor systems, supplied here in a 20 mg lyophilized vial format.\u003c\/p\u003e\n\n\u003cp\u003e\n  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% (HPLC-MS verified)\u003cbr\u003e\n  \u003cstrong\u003eFormat:\u003c\/strong\u003e 20mg lyophilized vial, sealed amber glass\u003cbr\u003e\n  \u003cstrong\u003eDesignation:\u003c\/strong\u003e Research use only — not intended for human or veterinary use\n\u003c\/p\u003e\n\n\u003ch2\u003eCompound Overview\u003c\/h2\u003e\n\u003cp\u003eRetatrutide is classified within the multi-receptor incretin research peptide family. It is engineered as a unimolecular agonist that concurrently engages three structurally related receptor systems: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon.\u003c\/p\u003e\n\n\u003cp\u003eThe 20 mg vial format offers a higher peptide content per vial than the 10 mg specification, suited to laboratory workflows requiring expanded comparative or repeat-assay material. Within peer-reviewed publications, Retatrutide is positioned as the triple-agonist endpoint of the unimolecular incretin research lineage.\u003c\/p\u003e\n\n\u003ch2\u003eResearch Context\u003c\/h2\u003e\n\u003cp\u003eRetatrutide has been investigated in published research literature and is commonly referenced in laboratory work involving:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eComparative incretin receptor pharmacology\u003c\/li\u003e\n  \u003cli\u003eUnimolecular multi-agonist peptide structure–activity research\u003c\/li\u003e\n  \u003cli\u003eEnergy substrate signaling pathway models\u003c\/li\u003e\n  \u003cli\u003eGlucose homeostasis and metabolic signaling research\u003c\/li\u003e\n  \u003cli\u003eComparative peptide pharmacokinetics and stability profiling\u003c\/li\u003e\n  \u003cli\u003eReceptor binding affinity and selectivity studies\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eScientific Classification\u003c\/h2\u003e\n\u003ctable\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCompound name\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eRetatrutide\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eMolecular class\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSynthetic peptide\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFunctional category\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eUnimolecular triple agonist (GLP-1 \/ GIP \/ glucagon)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePeptide family\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eIncretin-class multi-receptor agonist research peptides\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eResearch domains\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eIncretin biology, metabolic signaling, peptide pharmacology, receptor agonism\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAdjacent compounds\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eTirzepatide, Semaglutide, Cagrilintide, Cagrisema, Survodutide, Mazdutide, AOD9604, HGH Fragment 176-191\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eAnalytical \u0026amp; Quality Standards\u003c\/h2\u003e\n\u003cp\u003eEvery Retatrutide lot supplied by DISSOLV LABS undergoes a structured analytical workflow designed to confirm identity, purity, and batch consistency before release.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePurity verification\u003c\/strong\u003e by reversed-phase high-performance liquid chromatography (RP-HPLC)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIdentity confirmation\u003c\/strong\u003e by mass spectrometry (HPLC-MS)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResidual solvent and moisture screening\u003c\/strong\u003e to documented thresholds\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBatch-to-batch consistency\u003c\/strong\u003e recorded on a per-lot Certificate of Analysis (COA)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThird-party verification\u003c\/strong\u003e available upon institutional request\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSterile lyophilization\u003c\/strong\u003e under inert conditions to preserve peptide integrity\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eTechnical Specifications\u003c\/h2\u003e\n\u003ctable\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFormat\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e20mg lyophilized vial\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAppearance\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eUniform, free-flowing white lyophilized solid\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePackaging\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSealed amber glass vial, crimped seal\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCatalog identifier\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eDSL-RETA-0020\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePurity\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e≥99% (HPLC-MS verified)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eRecommended storage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e−20 °C, protected from light and moisture\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eReconstitution\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSterile or bacteriostatic solvent (laboratory protocol only)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eStability\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eStable under recommended storage conditions; refer to lot COA\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eHandling\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eRestricted to qualified research personnel\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow does the 20 mg vial differ from the 10 mg vial?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eThe 10 mg and 20 mg formats are analytically identical. They differ only in total peptide content per vial.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow does Retatrutide differ from Tirzepatide and Semaglutide?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eSemaglutide is described as a single-receptor GLP-1 agonist, Tirzepatide as a dual GLP-1\/GIP agonist, and Retatrutide as a unimolecular triple agonist engaging GLP-1, GIP, and glucagon receptors.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat purity standard does DISSOLV LABS supply?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eDISSOLV LABS supplies Retatrutide at \u003cstrong\u003e≥99% purity\u003c\/strong\u003e, verified by reversed-phase HPLC and confirmed by mass spectrometry (HPLC-MS). Each lot is accompanied by a Certificate of Analysis.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat analytical testing is performed on each lot?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eEach Retatrutide lot is subjected to RP-HPLC purity analysis, HPLC-MS identity confirmation, residual solvent and moisture screening, and batch-consistency documentation. Third-party analytical verification is available upon institutional request.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow should Retatrutide be stored?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eRecommended storage is \u003cstrong\u003e−20 °C\u003c\/strong\u003e, protected from light and moisture, in the original sealed vial. Refer to the lot-specific Certificate of Analysis for stability data.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow is Retatrutide reconstituted for laboratory work?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eRetatrutide is typically reconstituted with sterile or bacteriostatic solvent in accordance with the receiving laboratory's internal protocols. Reconstitution methodology is the responsibility of the qualified research professional.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eIs Retatrutide research use only?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eYes. Retatrutide supplied by DISSOLV LABS is \u003cstrong\u003estrictly for laboratory research use only\u003c\/strong\u003e. It is not intended for human or veterinary use, and is not intended to diagnose, treat, cure, or prevent any disease.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eIs a Certificate of Analysis (COA) available?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eYes. Every lot is shipped with a lot-specific Certificate of Analysis documenting purity, identity, and analytical methodology. COAs are available to verified research accounts on request.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWho should handle Retatrutide?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eRetatrutide is intended exclusively for handling by qualified laboratory research professionals operating within appropriate research facilities. It is not for sale to or use by the general public.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003ch2\u003eRelated Research Compounds\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003cstrong\u003eTirzepatide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eSemaglutide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eCagrilintide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eCagrisema\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eSurvodutide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eMazdutide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eAOD9604\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eHGH Fragment 176-191\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eCompliance\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only.\u003c\/strong\u003e This product is not intended for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Sale and distribution are restricted to qualified laboratory research professionals operating within appropriate research environments. The purchaser assumes full responsibility for safe handling, storage, and disposal in accordance with applicable institutional, local, and federal guidelines.\u003c\/p\u003e","brand":"DISSOLV LABS","offers":[{"title":"Default Title","offer_id":52102992199960,"sku":"DSL-RETA-0020","price":54.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0987\/0861\/9544\/files\/Retatrutide_20mg.png?v=1779524289"},{"product_id":"semaglutide-10mg","title":"Semaglutide 10mg","description":"\u003ch2\u003eSemaglutide — Research Peptide\u003c\/h2\u003e\n\u003cp\u003eSemaglutide is a synthetic long-acting peptide referenced in the scientific literature as a selective \u003cstrong\u003eGLP-1 receptor agonist\u003c\/strong\u003e. It is one of the most extensively profiled compounds within the incretin-class research peptide family.\u003c\/p\u003e\n\n\u003cp\u003e\n  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% (HPLC-MS verified)\u003cbr\u003e\n  \u003cstrong\u003eFormat:\u003c\/strong\u003e 10mg lyophilized vial, sealed amber glass\u003cbr\u003e\n  \u003cstrong\u003eDesignation:\u003c\/strong\u003e Research use only — not intended for human or veterinary use\n\u003c\/p\u003e\n\n\u003ch2\u003eCompound Overview\u003c\/h2\u003e\n\u003cp\u003eSemaglutide is a structurally modified glucagon-like peptide-1 (GLP-1) analog engineered with a fatty acid side chain that extends half-life relative to native GLP-1. Within the published literature, it is classified as a selective single-receptor agonist of the GLP-1 receptor system.\u003c\/p\u003e\n\n\u003cp\u003eSemaglutide is frequently positioned as the single-agonist baseline against which newer multi-receptor research peptides — including Tirzepatide (dual GLP-1\/GIP) and Retatrutide (triple GLP-1\/GIP\/glucagon) — are studied. It is among the most cited compounds in modern metabolic and endocrine peptide research literature.\u003c\/p\u003e\n\n\u003ch2\u003eResearch Context\u003c\/h2\u003e\n\u003cp\u003eSemaglutide has been investigated in published research literature and is commonly referenced in laboratory work involving:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eGLP-1 receptor pharmacology and signaling\u003c\/li\u003e\n  \u003cli\u003eLong-acting peptide design and fatty acid acylation strategies\u003c\/li\u003e\n  \u003cli\u003eIncretin biology and receptor selectivity studies\u003c\/li\u003e\n  \u003cli\u003eComparative pharmacokinetics across GLP-1 analogs\u003c\/li\u003e\n  \u003cli\u003eGlucose homeostasis and metabolic signaling research\u003c\/li\u003e\n  \u003cli\u003eReference-standard comparisons for multi-agonist peptide development\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eScientific Classification\u003c\/h2\u003e\n\u003ctable\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCompound name\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSemaglutide\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eMolecular class\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSynthetic peptide (modified GLP-1 analog)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFunctional category\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSelective GLP-1 receptor agonist\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePeptide family\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eIncretin-class research peptides\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eResearch domains\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eIncretin biology, GLP-1 receptor pharmacology, peptide pharmacokinetics, metabolic signaling\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAdjacent compounds\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eTirzepatide, Retatrutide, Cagrilintide, Cagrisema, Survodutide, Mazdutide, AOD9604, HGH Fragment 176-191\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eAnalytical \u0026amp; Quality Standards\u003c\/h2\u003e\n\u003cp\u003eEvery Semaglutide lot supplied by DISSOLV LABS undergoes a structured analytical workflow designed to confirm identity, purity, and batch consistency before release.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePurity verification\u003c\/strong\u003e by reversed-phase high-performance liquid chromatography (RP-HPLC)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIdentity confirmation\u003c\/strong\u003e by mass spectrometry (HPLC-MS)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResidual solvent and moisture screening\u003c\/strong\u003e to documented thresholds\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBatch-to-batch consistency\u003c\/strong\u003e recorded on a per-lot Certificate of Analysis (COA)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThird-party verification\u003c\/strong\u003e available upon institutional request\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSterile lyophilization\u003c\/strong\u003e under inert conditions to preserve peptide integrity\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eTechnical Specifications\u003c\/h2\u003e\n\u003ctable\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFormat\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e10mg lyophilized vial\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAppearance\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eUniform, free-flowing white lyophilized solid\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePackaging\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSealed amber glass vial, crimped seal\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCatalog identifier\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eDSL-SEMA-0010\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePurity\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e≥99% (HPLC-MS verified)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eRecommended storage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e−20 °C, protected from light and moisture\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eReconstitution\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSterile or bacteriostatic solvent (laboratory protocol only)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eStability\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eStable under recommended storage conditions; refer to lot COA\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eHandling\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eRestricted to qualified research personnel\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow does Semaglutide compare to Tirzepatide and Retatrutide?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eSemaglutide is a selective single-receptor GLP-1 agonist, Tirzepatide a dual GLP-1\/GIP agonist, and Retatrutide a unimolecular triple agonist engaging GLP-1, GIP, and glucagon receptors.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat purity standard does DISSOLV LABS supply?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eDISSOLV LABS supplies Semaglutide at \u003cstrong\u003e≥99% purity\u003c\/strong\u003e, verified by reversed-phase HPLC and confirmed by mass spectrometry (HPLC-MS). Each lot is accompanied by a Certificate of Analysis.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat analytical testing is performed on each lot?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eEach Semaglutide lot is subjected to RP-HPLC purity analysis, HPLC-MS identity confirmation, residual solvent and moisture screening, and batch-consistency documentation. Third-party analytical verification is available upon institutional request.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow should Semaglutide be stored?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eRecommended storage is \u003cstrong\u003e−20 °C\u003c\/strong\u003e, protected from light and moisture, in the original sealed vial. Refer to the lot-specific Certificate of Analysis for stability data.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow is Semaglutide reconstituted for laboratory work?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eSemaglutide is typically reconstituted with sterile or bacteriostatic solvent in accordance with the receiving laboratory's internal protocols. Reconstitution methodology is the responsibility of the qualified research professional.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eIs Semaglutide research use only?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eYes. Semaglutide supplied by DISSOLV LABS is \u003cstrong\u003estrictly for laboratory research use only\u003c\/strong\u003e. It is not intended for human or veterinary use, and is not intended to diagnose, treat, cure, or prevent any disease.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eIs a Certificate of Analysis (COA) available?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eYes. Every lot is shipped with a lot-specific Certificate of Analysis documenting purity, identity, and analytical methodology. COAs are available to verified research accounts on request.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWho should handle Semaglutide?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eSemaglutide is intended exclusively for handling by qualified laboratory research professionals operating within appropriate research facilities. It is not for sale to or use by the general public.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003ch2\u003eRelated Research Compounds\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003cstrong\u003eTirzepatide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eRetatrutide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eCagrilintide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eCagrisema\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eSurvodutide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eMazdutide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eAOD9604\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eHGH Fragment 176-191\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eCompliance\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only.\u003c\/strong\u003e This product is not intended for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Sale and distribution are restricted to qualified laboratory research professionals operating within appropriate research environments. The purchaser assumes full responsibility for safe handling, storage, and disposal in accordance with applicable institutional, local, and federal guidelines.\u003c\/p\u003e","brand":"DISSOLV LABS","offers":[{"title":"Default Title","offer_id":52102992232728,"sku":"DSL-SEMA-0010","price":17.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0987\/0861\/9544\/files\/Semaglutide_10.png?v=1779619257"},{"product_id":"semaglutide-20mg","title":"Semaglutide 20mg","description":"\u003ch2\u003eSemaglutide — Research Peptide\u003c\/h2\u003e\n\u003cp\u003eSemaglutide is a synthetic long-acting peptide referenced in the scientific literature as a selective \u003cstrong\u003eGLP-1 receptor agonist\u003c\/strong\u003e, supplied here in a 20 mg lyophilized vial format.\u003c\/p\u003e\n\n\u003cp\u003e\n  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% (HPLC-MS verified)\u003cbr\u003e\n  \u003cstrong\u003eFormat:\u003c\/strong\u003e 20mg lyophilized vial, sealed amber glass\u003cbr\u003e\n  \u003cstrong\u003eDesignation:\u003c\/strong\u003e Research use only — not intended for human or veterinary use\n\u003c\/p\u003e\n\n\u003ch2\u003eCompound Overview\u003c\/h2\u003e\n\u003cp\u003eSemaglutide is a structurally modified glucagon-like peptide-1 (GLP-1) analog engineered with a fatty acid side chain that extends half-life relative to native GLP-1. It is classified within the published literature as a selective single-receptor GLP-1 agonist and serves as a foundational reference compound for comparative incretin research.\u003c\/p\u003e\n\n\u003cp\u003eThe 20 mg vial format provides expanded peptide content for laboratory workflows requiring extended or repeat-assay material. Semaglutide remains the most heavily cited single-agonist incretin reference compound in modern metabolic research literature.\u003c\/p\u003e\n\n\u003ch2\u003eResearch Context\u003c\/h2\u003e\n\u003cp\u003eSemaglutide has been investigated in published research literature and is commonly referenced in laboratory work involving:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eGLP-1 receptor pharmacology and signaling\u003c\/li\u003e\n  \u003cli\u003eLong-acting peptide design and fatty acid acylation strategies\u003c\/li\u003e\n  \u003cli\u003eIncretin biology and receptor selectivity studies\u003c\/li\u003e\n  \u003cli\u003eComparative pharmacokinetics across GLP-1 analogs\u003c\/li\u003e\n  \u003cli\u003eGlucose homeostasis and metabolic signaling research\u003c\/li\u003e\n  \u003cli\u003eReference-standard comparisons for multi-agonist peptide development\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eScientific Classification\u003c\/h2\u003e\n\u003ctable\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCompound name\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSemaglutide\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eMolecular class\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSynthetic peptide (modified GLP-1 analog)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFunctional category\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSelective GLP-1 receptor agonist\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePeptide family\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eIncretin-class research peptides\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eResearch domains\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eIncretin biology, GLP-1 receptor pharmacology, peptide pharmacokinetics, metabolic signaling\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAdjacent compounds\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eTirzepatide, Retatrutide, Cagrilintide, Cagrisema, Survodutide, Mazdutide, AOD9604, HGH Fragment 176-191\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eAnalytical \u0026amp; Quality Standards\u003c\/h2\u003e\n\u003cp\u003eEvery Semaglutide lot supplied by DISSOLV LABS undergoes a structured analytical workflow designed to confirm identity, purity, and batch consistency before release.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePurity verification\u003c\/strong\u003e by reversed-phase high-performance liquid chromatography (RP-HPLC)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIdentity confirmation\u003c\/strong\u003e by mass spectrometry (HPLC-MS)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResidual solvent and moisture screening\u003c\/strong\u003e to documented thresholds\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBatch-to-batch consistency\u003c\/strong\u003e recorded on a per-lot Certificate of Analysis (COA)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThird-party verification\u003c\/strong\u003e available upon institutional request\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSterile lyophilization\u003c\/strong\u003e under inert conditions to preserve peptide integrity\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eTechnical Specifications\u003c\/h2\u003e\n\u003ctable\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFormat\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e20mg lyophilized vial\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAppearance\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eUniform, free-flowing white lyophilized solid\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePackaging\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSealed amber glass vial, crimped seal\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCatalog identifier\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eDSL-SEMA-0020\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePurity\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e≥99% (HPLC-MS verified)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eRecommended storage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e−20 °C, protected from light and moisture\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eReconstitution\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSterile or bacteriostatic solvent (laboratory protocol only)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eStability\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eStable under recommended storage conditions; refer to lot COA\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eHandling\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eRestricted to qualified research personnel\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow does the 20 mg vial differ from the 10 mg vial?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eThe 10 mg and 20 mg formats are analytically identical — same compound, same ≥99% purity specification, same lyophilization protocol. They differ only in total peptide content per vial.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow does Semaglutide compare to Tirzepatide and Retatrutide?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eSemaglutide is a selective single-receptor GLP-1 agonist, Tirzepatide a dual GLP-1\/GIP agonist, and Retatrutide a unimolecular triple agonist.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat purity standard does DISSOLV LABS supply?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eDISSOLV LABS supplies Semaglutide at \u003cstrong\u003e≥99% purity\u003c\/strong\u003e, verified by reversed-phase HPLC and confirmed by mass spectrometry (HPLC-MS). Each lot is accompanied by a Certificate of Analysis.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat analytical testing is performed on each lot?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eEach Semaglutide lot is subjected to RP-HPLC purity analysis, HPLC-MS identity confirmation, residual solvent and moisture screening, and batch-consistency documentation. Third-party analytical verification is available upon institutional request.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow should Semaglutide be stored?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eRecommended storage is \u003cstrong\u003e−20 °C\u003c\/strong\u003e, protected from light and moisture, in the original sealed vial. Refer to the lot-specific Certificate of Analysis for stability data.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow is Semaglutide reconstituted for laboratory work?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eSemaglutide is typically reconstituted with sterile or bacteriostatic solvent in accordance with the receiving laboratory's internal protocols. Reconstitution methodology is the responsibility of the qualified research professional.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eIs Semaglutide research use only?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eYes. Semaglutide supplied by DISSOLV LABS is \u003cstrong\u003estrictly for laboratory research use only\u003c\/strong\u003e. It is not intended for human or veterinary use, and is not intended to diagnose, treat, cure, or prevent any disease.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eIs a Certificate of Analysis (COA) available?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eYes. Every lot is shipped with a lot-specific Certificate of Analysis documenting purity, identity, and analytical methodology. COAs are available to verified research accounts on request.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWho should handle Semaglutide?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eSemaglutide is intended exclusively for handling by qualified laboratory research professionals operating within appropriate research facilities. It is not for sale to or use by the general public.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003ch2\u003eRelated Research Compounds\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003cstrong\u003eTirzepatide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eRetatrutide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eCagrilintide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eCagrisema\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eSurvodutide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eMazdutide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eAOD9604\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eHGH Fragment 176-191\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eCompliance\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only.\u003c\/strong\u003e This product is not intended for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Sale and distribution are restricted to qualified laboratory research professionals operating within appropriate research environments. The purchaser assumes full responsibility for safe handling, storage, and disposal in accordance with applicable institutional, local, and federal guidelines.\u003c\/p\u003e","brand":"DISSOLV LABS","offers":[{"title":"Default Title","offer_id":52102992265496,"sku":"DSL-SEMA-0020","price":25.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0987\/0861\/9544\/files\/Semaglutide_20mg.png?v=1779524293"},{"product_id":"cagrilintide-5mg","title":"Cagrilintide 5mg","description":"\u003ch2\u003eCagrilintide — Research Peptide\u003c\/h2\u003e\n\u003cp\u003eCagrilintide is a synthetic long-acting peptide referenced in the scientific literature as a \u003cstrong\u003eselective amylin and calcitonin receptor agonist\u003c\/strong\u003e. It is classified within the amylin analog research peptide family.\u003c\/p\u003e\n\n\u003cp\u003e\n  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% (HPLC-MS verified)\u003cbr\u003e\n  \u003cstrong\u003eFormat:\u003c\/strong\u003e 5mg lyophilized vial, sealed amber glass\u003cbr\u003e\n  \u003cstrong\u003eDesignation:\u003c\/strong\u003e Research use only — not intended for human or veterinary use\n\u003c\/p\u003e\n\n\u003ch2\u003eCompound Overview\u003c\/h2\u003e\n\u003cp\u003eCagrilintide is a structurally modified amylin analog engineered with a fatty acid side chain that extends half-life relative to native amylin. It is classified as a long-acting dual agonist of the amylin and calcitonin receptor systems.\u003c\/p\u003e\n\n\u003cp\u003eCagrilintide is most often studied in adjacency to Semaglutide and is the amylin-class component of the combination research compound Cagrisema. As a reference standard, it occupies a complementary role to the incretin-class peptides.\u003c\/p\u003e\n\n\u003ch2\u003eResearch Context\u003c\/h2\u003e\n\u003cp\u003eCagrilintide has been investigated in published research literature and is commonly referenced in laboratory work involving:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eAmylin and calcitonin receptor pharmacology\u003c\/li\u003e\n  \u003cli\u003eLong-acting amylin analog design and fatty acid acylation strategies\u003c\/li\u003e\n  \u003cli\u003eComparative receptor selectivity and binding affinity studies\u003c\/li\u003e\n  \u003cli\u003eCo-administration research with GLP-1 receptor agonists\u003c\/li\u003e\n  \u003cli\u003eCombination peptide research within the Cagrisema framework\u003c\/li\u003e\n  \u003cli\u003eMetabolic signaling and satiety pathway models\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eScientific Classification\u003c\/h2\u003e\n\u003ctable\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCompound name\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCagrilintide\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eMolecular class\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSynthetic peptide (modified amylin analog)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFunctional category\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eLong-acting amylin and calcitonin receptor agonist\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePeptide family\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eAmylin analog research peptides\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eResearch domains\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eAmylin receptor pharmacology, calcitonin receptor signaling, peptide pharmacokinetics, metabolic signaling\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAdjacent compounds\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSemaglutide, Tirzepatide, Retatrutide, Cagrisema, AOD9604, HGH Fragment 176-191\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eAnalytical \u0026amp; Quality Standards\u003c\/h2\u003e\n\u003cp\u003eEvery Cagrilintide lot supplied by DISSOLV LABS undergoes a structured analytical workflow designed to confirm identity, purity, and batch consistency before release.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePurity verification\u003c\/strong\u003e by reversed-phase high-performance liquid chromatography (RP-HPLC)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIdentity confirmation\u003c\/strong\u003e by mass spectrometry (HPLC-MS)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResidual solvent and moisture screening\u003c\/strong\u003e to documented thresholds\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBatch-to-batch consistency\u003c\/strong\u003e recorded on a per-lot Certificate of Analysis (COA)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThird-party verification\u003c\/strong\u003e available upon institutional request\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSterile lyophilization\u003c\/strong\u003e under inert conditions to preserve peptide integrity\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eTechnical Specifications\u003c\/h2\u003e\n\u003ctable\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFormat\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e5mg lyophilized vial\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAppearance\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eUniform, free-flowing white lyophilized solid\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePackaging\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSealed amber glass vial, crimped seal\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCatalog identifier\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eDSL-CAGRI-0005\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePurity\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e≥99% (HPLC-MS verified)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eRecommended storage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e−20 °C, protected from light and moisture\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eReconstitution\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSterile or bacteriostatic solvent (laboratory protocol only)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eStability\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eStable under recommended storage conditions; refer to lot COA\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eHandling\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eRestricted to qualified research personnel\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow does Cagrilintide differ from Semaglutide?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eCagrilintide is a long-acting amylin and calcitonin receptor agonist, while Semaglutide is a selective GLP-1 receptor agonist. They act on distinct receptor systems and are frequently studied in combination within the Cagrisema research framework.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat is the relationship between Cagrilintide and Cagrisema?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eCagrisema is a combination research compound pairing Cagrilintide (amylin analog) with Semaglutide (GLP-1 agonist). Cagrilintide is the amylin-class component of that pairing.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat purity standard does DISSOLV LABS supply?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eDISSOLV LABS supplies Cagrilintide at \u003cstrong\u003e≥99% purity\u003c\/strong\u003e, verified by reversed-phase HPLC and confirmed by mass spectrometry (HPLC-MS). Each lot is accompanied by a Certificate of Analysis.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat analytical testing is performed on each lot?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eEach Cagrilintide lot is subjected to RP-HPLC purity analysis, HPLC-MS identity confirmation, residual solvent and moisture screening, and batch-consistency documentation. Third-party analytical verification is available upon institutional request.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow should Cagrilintide be stored?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eRecommended storage is \u003cstrong\u003e−20 °C\u003c\/strong\u003e, protected from light and moisture, in the original sealed vial. Refer to the lot-specific Certificate of Analysis for stability data.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow is Cagrilintide reconstituted for laboratory work?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eCagrilintide is typically reconstituted with sterile or bacteriostatic solvent in accordance with the receiving laboratory's internal protocols. Reconstitution methodology is the responsibility of the qualified research professional.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eIs Cagrilintide research use only?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eYes. Cagrilintide supplied by DISSOLV LABS is \u003cstrong\u003estrictly for laboratory research use only\u003c\/strong\u003e. It is not intended for human or veterinary use, and is not intended to diagnose, treat, cure, or prevent any disease.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eIs a Certificate of Analysis (COA) available?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eYes. Every lot is shipped with a lot-specific Certificate of Analysis documenting purity, identity, and analytical methodology. COAs are available to verified research accounts on request.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWho should handle Cagrilintide?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eCagrilintide is intended exclusively for handling by qualified laboratory research professionals operating within appropriate research facilities. It is not for sale to or use by the general public.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003ch2\u003eRelated Research Compounds\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003cstrong\u003eSemaglutide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eTirzepatide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eRetatrutide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eCagrisema\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eAOD9604\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eHGH Fragment 176-191\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eCompliance\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only.\u003c\/strong\u003e This product is not intended for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Sale and distribution are restricted to qualified laboratory research professionals operating within appropriate research environments. The purchaser assumes full responsibility for safe handling, storage, and disposal in accordance with applicable institutional, local, and federal guidelines.\u003c\/p\u003e","brand":"DISSOLV LABS","offers":[{"title":"Default Title","offer_id":52102992298264,"sku":"DSL-CAGRI-0005","price":43.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0987\/0861\/9544\/files\/Carglintide5mg.png?v=1779619963"},{"product_id":"cagrisema-5mg-plus-5mg","title":"Cagrisema 5mg + 5mg","description":"\u003ch2\u003eCagrisema — Research Peptide\u003c\/h2\u003e\n\u003cp\u003eCagrisema is a combination research peptide pairing \u003cstrong\u003eCagrilintide\u003c\/strong\u003e (amylin analog) with \u003cstrong\u003eSemaglutide\u003c\/strong\u003e (GLP-1 agonist) at 5 mg of each component per vial. It is one of the most studied combination peptide compounds within the comparative incretin–amylin research literature.\u003c\/p\u003e\n\n\u003cp\u003e\n  \u003cstrong\u003ePurity:\u003c\/strong\u003e ≥99% (HPLC-MS verified)\u003cbr\u003e\n  \u003cstrong\u003eFormat:\u003c\/strong\u003e 5mg + 5mg lyophilized vial, sealed amber glass\u003cbr\u003e\n  \u003cstrong\u003eDesignation:\u003c\/strong\u003e Research use only — not intended for human or veterinary use\n\u003c\/p\u003e\n\n\u003ch2\u003eCompound Overview\u003c\/h2\u003e\n\u003cp\u003eCagrisema is supplied as a combination research formulation containing 5 mg of Cagrilintide and 5 mg of Semaglutide per vial. The pairing combines a long-acting amylin\/calcitonin receptor agonist with a selective GLP-1 receptor agonist, providing a single-vial reference compound for combination peptide research.\u003c\/p\u003e\n\n\u003cp\u003eWithin the published literature, Cagrisema is frequently positioned alongside dual unimolecular agonists such as Tirzepatide (GLP-1\/GIP) and Survodutide (GLP-1\/glucagon), and alongside the triple agonist Retatrutide, as part of the broader comparative multi-pathway incretin research lineage.\u003c\/p\u003e\n\n\u003ch2\u003eResearch Context\u003c\/h2\u003e\n\u003cp\u003eCagrisema has been investigated in published research literature and is commonly referenced in laboratory work involving:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eCombination peptide pharmacology research\u003c\/li\u003e\n  \u003cli\u003eAmylin and GLP-1 receptor co-engagement research\u003c\/li\u003e\n  \u003cli\u003eComparative multi-pathway incretin research\u003c\/li\u003e\n  \u003cli\u003eCombination peptide pharmacokinetics and stability profiling\u003c\/li\u003e\n  \u003cli\u003eMetabolic signaling and satiety pathway models\u003c\/li\u003e\n  \u003cli\u003eReceptor binding affinity and selectivity studies\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eScientific Classification\u003c\/h2\u003e\n\u003ctable\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCompound name\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCagrisema\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eMolecular class\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCombination research formulation (two synthetic peptides)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFunctional category\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCombination amylin \/ GLP-1 receptor agonist research compound\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePeptide family\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCombination incretin\/amylin research peptides\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eResearch domains\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCombination peptide pharmacology, amylin–GLP-1 co-administration research, metabolic signaling, comparative incretin research\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAdjacent compounds\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eCagrilintide, Semaglutide, Tirzepatide, Retatrutide, Survodutide, Mazdutide\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eAnalytical \u0026amp; Quality Standards\u003c\/h2\u003e\n\u003cp\u003eEvery Cagrisema lot supplied by DISSOLV LABS undergoes a structured analytical workflow designed to confirm identity, purity, and batch consistency before release.\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003ePurity verification\u003c\/strong\u003e by reversed-phase high-performance liquid chromatography (RP-HPLC)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eIdentity confirmation\u003c\/strong\u003e by mass spectrometry (HPLC-MS)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eResidual solvent and moisture screening\u003c\/strong\u003e to documented thresholds\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eBatch-to-batch consistency\u003c\/strong\u003e recorded on a per-lot Certificate of Analysis (COA)\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eThird-party verification\u003c\/strong\u003e available upon institutional request\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eSterile lyophilization\u003c\/strong\u003e under inert conditions to preserve peptide integrity\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eTechnical Specifications\u003c\/h2\u003e\n\u003ctable\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eFormat\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e5mg + 5mg lyophilized vial\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eAppearance\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eUniform, free-flowing white lyophilized solid\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePackaging\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSealed amber glass vial, crimped seal\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCatalog identifier\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eDSL-CAGSM-0010\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePurity\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e≥99% (HPLC-MS verified)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eRecommended storage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e−20 °C, protected from light and moisture\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eReconstitution\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSterile or bacteriostatic solvent (laboratory protocol only)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eStability\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eStable under recommended storage conditions; refer to lot COA\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eHandling\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eRestricted to qualified research personnel\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat is in a Cagrisema vial?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eEach Cagrisema vial contains 5 mg of Cagrilintide and 5 mg of Semaglutide, supplied as a single co-lyophilized combination research formulation.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow does Cagrisema differ from a unimolecular dual agonist like Tirzepatide?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eTirzepatide is a single unimolecular peptide that engages two receptors. Cagrisema is a combination of two distinct peptides (Cagrilintide + Semaglutide) targeting amylin\/calcitonin and GLP-1 receptors respectively. They represent two distinct approaches to multi-pathway research within the incretin-amylin literature.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat purity standard does DISSOLV LABS supply?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eDISSOLV LABS supplies Cagrisema at \u003cstrong\u003e≥99% purity\u003c\/strong\u003e, verified by reversed-phase HPLC and confirmed by mass spectrometry (HPLC-MS). Each lot is accompanied by a Certificate of Analysis.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWhat analytical testing is performed on each lot?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eEach Cagrisema lot is subjected to RP-HPLC purity analysis, HPLC-MS identity confirmation, residual solvent and moisture screening, and batch-consistency documentation. Third-party analytical verification is available upon institutional request.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow should Cagrisema be stored?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eRecommended storage is \u003cstrong\u003e−20 °C\u003c\/strong\u003e, protected from light and moisture, in the original sealed vial. Refer to the lot-specific Certificate of Analysis for stability data.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eHow is Cagrisema reconstituted for laboratory work?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eCagrisema is typically reconstituted with sterile or bacteriostatic solvent in accordance with the receiving laboratory's internal protocols. Reconstitution methodology is the responsibility of the qualified research professional.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eIs Cagrisema research use only?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eYes. Cagrisema supplied by DISSOLV LABS is \u003cstrong\u003estrictly for laboratory research use only\u003c\/strong\u003e. It is not intended for human or veterinary use, and is not intended to diagnose, treat, cure, or prevent any disease.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eIs a Certificate of Analysis (COA) available?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eYes. Every lot is shipped with a lot-specific Certificate of Analysis documenting purity, identity, and analytical methodology. COAs are available to verified research accounts on request.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003cdetails\u003e\n  \u003csummary\u003e\u003cstrong\u003eWho should handle Cagrisema?\u003c\/strong\u003e\u003c\/summary\u003e\n  \u003cp\u003eCagrisema is intended exclusively for handling by qualified laboratory research professionals operating within appropriate research facilities. It is not for sale to or use by the general public.\u003c\/p\u003e\n\u003c\/details\u003e\n\n\u003ch2\u003eRelated Research Compounds\u003c\/h2\u003e\n\u003cul\u003e\n  \u003cli\u003e\u003cstrong\u003eCagrilintide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eSemaglutide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eTirzepatide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eRetatrutide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eSurvodutide\u003c\/strong\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003cstrong\u003eMazdutide\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ch2\u003eCompliance\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only.\u003c\/strong\u003e This product is not intended for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Sale and distribution are restricted to qualified laboratory research professionals operating within appropriate research environments. The purchaser assumes full responsibility for safe handling, storage, and disposal in accordance with applicable institutional, local, and federal guidelines.\u003c\/p\u003e","brand":"DISSOLV LABS","offers":[{"title":"Default Title","offer_id":52102992822552,"sku":"DSL-CAGSM-0010","price":37.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0987\/0861\/9544\/files\/Cagrisema_5mg_8c14bb10-2bbe-48da-89ca-20592ed9a76e.png?v=1779678436"}],"url":"https:\/\/dissolv.com\/collections\/glp-1.oembed","provider":"Dissolv Labs","version":"1.0","type":"link"}